TransMedics (TMDX) Cash from Investing Activities (2018 - 2026)

TransMedics has reported Cash from Investing Activities for 9 years, with the latest figure at -$36.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 35.58% year-over-year to -$36.7 million; the trailing twelve-month figure through Mar 2026 stood at -$68.9 million (up 38.6% YoY), and the FY2025 full-year result was -$59.3 million, up 54.18% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$36.7 million, down from -$15.5 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $24.7 million in Q3 2022, with the low at -$149.8 million in Q3 2023.
• Average Cash from Investing Activities over 5 years is -$21.5 million, with a median of -$13.6 million recorded in 2024.
• Year-over-year, Cash from Investing Activities soared 478.73% in 2022 and tumbled 4665.05% in 2024.
• Tracing TMDX's Cash from Investing Activities over 5 years: stood at -$2.8 million in 2022, then slumped by 1412.95% to -$41.8 million in 2023, then jumped by 67.46% to -$13.6 million in 2024, then decreased by 14.02% to -$15.5 million in 2025, then tumbled by 136.28% to -$36.7 million in 2026.
• The last three Cash from Investing Activities figures came in at -$36.7 million (Q1 2026), -$15.5 million (Q4 2025), and -$7.6 million (Q3 2025), per Business Quant data.

Peer Comparison